VTA Agenda
Evidence & Outcomes
Veterinary professionals should be able to judge technology by reliable evidence, not just supplier promises.
The problem
Veterinary technology is marketed using claims about time savings, productivity, accuracy, improved workflows, better client experiences and clinical benefits.
Some claims are supported by research or careful evaluation.
Others rely on demonstrations, selected customer examples or assumptions about how a product will be used.
These are not equivalent forms of evidence.
A product may work well in a demonstration but perform differently in a busy practice.
A tool that reduces one task may create additional work elsewhere.
A system that improves business efficiency may have no demonstrated effect on patient outcomes.
Veterinary professionals need a clearer way to assess such claims.
What needs to change
Clear descriptions of intended use
Suppliers should explain what a product is designed to do, which users and settings it is intended for, and any material limitations. Evidence should relate to those claims rather than to the broad category of technology in which the product sits.
Outcomes that can be measured
Claims should be linked to identifiable measures. Time savings should account for the work required to review and correct outputs. Improvements in access should be measured against relevant service outcomes. Claims about diagnostic performance should report meaningful accuracy measures in an appropriate clinical context.
A distinction between operational and clinical benefit
Faster administration, improved communication and reduced costs can benefit practices. But these should not automatically be presented as evidence of better clinical outcomes. Where a supplier claims a benefit for animal health, the supporting evidence should address that outcome.
Transparent methods and limitations
The strength of evidence depends on how it was produced. Relevant questions include the size and selection of the sample, the conditions of testing, the measures used, the existence of a suitable comparison and whether findings have been independently examined. Negative findings and important limitations should not be omitted simply because they make a product less attractive commercially.
Proportionate expectations
Not every product requires a clinical trial. A scheduling tool, an AI diagnostic system and a connected monitoring device present different questions and risks. Evidence requirements should reflect those differences.
Evaluation in real practice
Technology should be assessed in the circumstances where it will be used. Veterinary teams should be able to understand whether published benefits are likely to apply to their own workflows, facilities, patients and staff.
Questions for members
- What information should suppliers provide when making performance claims?
- How should clinical and operational outcomes be distinguished?
- What constitutes reasonable evidence for different categories of veterinary technology?
- How can veterinary professionals assess whether reported time savings apply to their practice?
- How should independent research and third-party evaluation contribute?
- Can the industry develop a shared approach to reporting important limitations?
- How can technology companies support comparative research without compromising its independence?
What we want to work towards
A practical approach to describing intended use, presenting evidence and reporting outcomes across veterinary technology.
One possible starting point is a common evidence disclosure template.
This could help practices understand the basis of product claims without implying that all technologies need identical evaluation methods.
The VTA should encourage credible evidence and responsible communication, not create another marketing badge or endorsement scheme.
The aim is to make it easier for veterinary professionals to assess technology and for suppliers to demonstrate the benefits their products genuinely deliver.
Membership is open
Join the founding cohort of the Veterinary Technology Association and help set the agenda rather than react to it.